.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Citi
McKinsey
Julphar
Queensland Health
Teva
Merck
Express Scripts
Cipla
Boehringer Ingelheim

Generated: July 20, 2017

DrugPatentWatch Database Preview

BIDIL Drug Profile

« Back to Dashboard

What is the patent landscape for Bidil, and when can generic versions of Bidil launch?

Bidil is a drug marketed by Arbor Pharms Llc and is included in one NDA. There are two patents protecting this drug.

This drug has four patent family members in four countries.

The generic ingredient in BIDIL is hydralazine hydrochloride; isosorbide dinitrate. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydralazine hydrochloride; isosorbide dinitrate profile page.

Summary for Tradename: BIDIL

Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list33
Clinical Trials: see list5
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BIDIL at DailyMed

Pharmacology for Tradename: BIDIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc
BIDIL
hydralazine hydrochloride; isosorbide dinitrate
TABLET;ORAL020727-001Jun 23, 2005RXYesYes6,784,177► Subscribe ► Subscribe
Arbor Pharms Llc
BIDIL
hydralazine hydrochloride; isosorbide dinitrate
TABLET;ORAL020727-001Jun 23, 2005RXYesYes6,465,463► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BIDIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Arbor Pharms Llc
BIDIL
hydralazine hydrochloride; isosorbide dinitrate
TABLET;ORAL020727-001Jun 23, 20054,868,179► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: BIDIL

Country Document Number Estimated Expiration
Australia7365900► Subscribe
World Intellectual Property Organization (WIPO)0117528► Subscribe
European Patent Office1212053► Subscribe
Canada2383974► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Farmers Insurance
Daiichi Sankyo
US Army
Boehringer Ingelheim
QuintilesIMS
Fuji
Novartis
Medtronic
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot